Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ischemia Reperfusion Injury: early-phase trial registry
2 of 3 indexed Ischemia Reperfusion Injury trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Ischemia Reperfusion Injury: 3 US clinical trials tracked, 2 recruiting.
Ischemia Reperfusion Injury is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Kaiser Permanente, running 1 of these trials.
Enrollment posture brief
Registry condition ischemia-reperfusion-injury
OPEN 2 | RECR 67% | LATE 0 | EARLY 3 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Ischemia Reperfusion Injury lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ischemia Reperfusion Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ischemia Reperfusion Injury is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
Kaiser Permanente
NCT04750616
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
Rhode Island Hospital
NCT04005469
Intravenous Estrogen in Kidney Transplant Study
University of Pennsylvania
NCT03663543
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ischemia Reperfusion Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ischemia Reperfusion Injury trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ischemia Reperfusion Injury page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Ischemia Reperfusion Injury trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kaiser Permanente sponsors the most Ischemia Reperfusion Injury trials on record, review their full trial history before evaluating a specific study. See Kaiser Permanente's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemia Reperfusion Injury condition card totals 3 registered trials; most-linked intervention Conjugated Estrogen; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.